(2) what conclusions she has reached following the consultation on branded generic medicines on their potential to produce savings for the NHS; and if she will make a statement.
The Department has received the report of the Office of Fair Trading's market study of the pharmaceutical price regulation scheme and will consider its findings on this matter before we finally decide upon what action to take concerning branded generic medicines.